Abstract B029: Incidence of grade II or higher hematologic toxicities in ovarian cancer patients on concurrent poly-ADP ribose polymerase inhibitor therapy and anti-Xa inhibition therapy
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Julia Taylor, Miranda Benfield, Zahra Bahrani-Mostafavi, Kelley Kaczmarski, Allison Puechl
Institutions: Carolinas Medical Center, Levine Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414350069
Cites:
Cited by:
Related to: